Overactive Bladder
Neuromodulation techniques for managing overactive bladder.
- Details
Overactive bladder (OAB) represents a significant burden and has a considerable impact on the quality of life (QoL) of affected patients. The treatment of this condition poses notable challenges due to its multifactorial pathophysiology and the frequent refractoriness to standard pharmacological therapies.
Prevalence and risk factors of overactive bladder syndrome among Egyptian medical students, and its impact on health-related quality of life, cross-sectional study.
- Details
Overactive bladder (OAB) is a common chronic condition that can have a significant impact on quality of life (HRQL). We aimed to assess the prevalence of OAB bother and its related quality of life among medical students in Egypt.
Association between hepatitis C virus and overactive bladder: a cross-sectional study based on the 2013-2018 NHANES.
- Details
Overactive bladder (OAB) is a common urological disorder with an incompletely understood pathogenesis that markedly impacts patients' quality of life, and hepatitis C virus (HCV) infection is associated with systemic inflammation and extrahepatic complications, with their potential association remaining understudied.
Impact of Adjunctive Myo-Inositol and Magnesium Therapy on Paediatric Overactive Bladder: A Retrospective Analysis.
- Details
Overactive bladder (OAB) is a common functional disorder in paediatric populations and is associated with significant psychological burden and impaired quality of life. Although oxybutynin is widely used as first-line pharmacological therapy, a substantial proportion of children exhibit incomplete symptom control or limited tolerability.
Chinese American Women's Overactive Bladder Care Experience: A Qualitative Study.
- Details
Chinese American women often express dissatisfaction with their health care experiences, which have been linked to negative health outcomes. To our knowledge, their experiences and outcomes when seeking care for overactive bladder (OAB) remain undescribed.
Decision-Making in Refractory Overactive Bladder: Evaluation of a Novel Patient Decision Aid and its Impact on Decisional Conflict.
- Details
Refractory overactive bladder (OAB) lacks formal definition and is poorly understood. Its management requires patients to choose an invasive treatment, including intravesical botulinum toxin A (BOTOX®), sacral neuromodulation (SNM) and posterior tibial nerve stimulation (PTNS), which have varying rates of efficacy and side effects.
Treatment of refractory idiopathic overactive bladder with incobotulinumtoxinA and vibe delivery system (XAVIER): pilot study.
- Details
Intradetrusor botulinum neurotoxin type A (BoNT/A) with onabotulinumtoxinA (onabotA), is an established treatment for overactive bladder (OAB). This study aims to evaluate the safety, usability, and initial efficacy of ViXe - a combination of incobotulinumtoxinA with the needle-free, ultrasound-assisted intravesical Vibe delivery system - in women with OAB.
The Overactive and Poorly Compliant Bladder: a Review of Coexisting Detrusor Overactivity and Poor Compliance
- Details
Overactive bladder (OAB) and poorly compliant bladder are two urologic conditions that share overlapping symptoms, such as urinary frequency and incontinence, but arise from distinct etiologies. This review briefly outlines their pathophysiology and summarizes current management strategies.
Overactive Bladder 5 Years After the Mid-Urethral Sling Tensioning (MUST) Trial.
- Details
The midurethral sling (MUS) procedure is the gold standard surgical treatment for stress urinary incontinence; however, it can significantly affect symptoms of overactive bladder (OAB).
This study aimed to evaluate the burden of OAB 5 years after MUS insertion by analyzing medication prescriptions, surgical intervention and patient-reported data, with comparisons by sling tensioning technique.
The Relationship Between Urinary Caffeine With Caffeine Metabolites and Wet Overactive Bladder: A Cross-Sectional Study From NHANES 2009-2014 Data.
- Details
The potential relationship between urinary caffeine metabolites and wet overactive bladder (OAB) is not clear. This study aims to investigate the relationship between urinary caffeine with caffeine metabolites and wet OAB prevalence in American population.